Bionano Genomics (BNGO) Non Operating Income (2017 - 2026)
Bionano Genomics (BNGO) reported Non Operating Income of $223000.0 for Q1 2026, down 23.1% on a YoY basis from $290000.0 in Q1 2025, and up 104.24% sequentially from -$5.3 million in Q4 2025.
Bionano Genomics (BNGO) Non Operating Income (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of Non Operating Income data on file, last reported at $223000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 23.1% year-over-year to $223000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (down 218.56% YoY), and the FY2025 full-year result was $1.1 million, down 47.12% from the prior year.
- Non Operating Income improved to $223000.0 in Q1 2026, from -$5.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.9 million in Q4 2024 to a low of -$19.0 million in Q4 2023.
- A 5-year average of -$962375.0 and a median of $372000.0 in 2022 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 1168.97% in 2022 and sank 2564.16% in 2023, its largest moves.
- Tracing BNGO's Non Operating Income over 5 years: stood at $770000.0 in 2022, then slumped by 2564.16% to -$19.0 million in 2023, then surged by 110.11% to $1.9 million in 2024, then plunged by 374.21% to -$5.3 million in 2025, then surged by 104.24% to $223000.0 in 2026.
- Business Quant data shows BNGO's Non Operating Income at $223000.0 in Q1 2026, -$5.3 million in Q4 2025, and $49000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -131.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 12.29 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -62.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.93 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | 223,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 223,000.00 |
| Dec 31, 2025 | -5.26 Mn |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 953,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 820,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | -18.97 Mn |
| Sep 30, 2023 | 730,000.00 |
| Jun 30, 2023 | 359,000.00 |
| Mar 31, 2023 | 745,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Sep 30, 2022 | 368,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 65,000.00 |